EFdA-TP tetralithium

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

EFdA-TP tetralithium is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP tetralithium inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT). EFdA-TP tetralithium inhibits HIV-1 RT with multiple mechanisms.

For research use only. We do not sell to patients.

  • Purity: 96.91%
  • Formula: C12H11FLi4N5O12P3
  • Molecular Weight:556.93
  • Storage:

    -20°C, protect from light, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) EFdA-TP tetralithium

More

All HIV Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00